Skip to main content
Premium Trial:

Request an Annual Quote

Eisai Research to Use Genedata's Expressionist to Hunt Biomarkers

NEW YORK (GenomeWeb News) – The Eisai Research Institute will use Genedata’s Expressionist software in its biomarker discovery programs, Genedata said today.
 
The Expressionist platform integrates high-throughput data from transcriptomics, proteomics, metabolomics studies, and includes statistical analysis and interpretation functions.
 
Andover, Mass.-based ERI is a subsidiary of Japanese firm Eisai and is focused on several therapeutic programs, including studies of oncology, the central nervous system, and gastrointestinal diseases.
 
Financial terms of the agreement were not released.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more